Status:
COMPLETED
Influence of the Vitamin D Blood Levels on the Amyotrophic Lateral Sclerosis Phenotype
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
18-95 years
Phase:
NA
Brief Summary
The main objective of this study is to investigate the correlation between the rate of motor decline and blood levels of Vitamin D total. Secondary objectives are to investigate the relationship betwe...
Detailed Description
Amyotrophic lateral sclerosis is one of the most serious neurodegenerative disease, leading to death in 3 years by progressive paralysis of 4 limbs, speech, swallowing and breathing, and due to a prog...
Eligibility Criteria
Inclusion
- Subject with possible, probable or definite Amyotrophic Lateral Sclerosis (ALS).
- ALS operating for less than three years at dosage of vitamin D time.
- Subject monitored in the center ALS of Montpellier for 6 months.
- Subject agreeing to give his consent in writing or orally if the patient SLA is unable to write
Exclusion
- Subject has received a Vitamine D treatment in the six months preceding the inclusion
- Subject with a clinical condition on the inclusion day that makes it highly probable death in the year (quadriplegic patient, subject ventilated for respiratory failure in ALS, major malnutrition) or with ALSFRS-R score \<20.
- Pregnant or breastfeeding women
- Subject not covered by a social security scheme.
- Subject under guardianship
- Adult protected by the law
Key Trial Info
Start Date :
September 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
127 Patients enrolled
Trial Details
Trial ID
NCT01823380
Start Date
September 1 2012
End Date
September 1 2015
Last Update
December 7 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UH Montpellier
Montpellier, France, 34295